MedTrace Logo

High Dimensional Analysis of Immune Cells in Pediatric Patients

NCT05820802 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 294

Last updated 2024-11-29

No results posted yet for this study

Summary

The purpose of this study is to characterize immune cells using single-cell transcriptomic analysis in pediatric patients aged 2 to 18 years undergoing general anesthesia who are expected to receive Rocuronium, a non-depolarizing neuromuscular blocking agent, in the event of an allergic reaction.

Conditions

  • Drug Allergy
  • Neuromuscular Blockade

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Eligibility

Min Age
2 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-27
Primary Completion
2026-04-01
Completion
2026-12-01

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05820802 on ClinicalTrials.gov